Access to and use of high blood pressure medications in brazil
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2016 |
| Outros Autores: | , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da UNIFESP |
| Texto Completo: | http://dx.doi.org/10.1590/s1518-8787.2016050006154 http://repositorio.unifesp.br/handle/11600/49285 |
Resumo: | OBJECTIVE: To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS: Analysis of data from Pesquisa Nacional Sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS: Prevalence of high blood pressure was 23.7% (95% CI 22.8-24.6). Regarding people with this condition, 93.8% (95% CI 92.8-94.8) had indication for drug therapy and, of those, 94.6% (95% CI 93.5-95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95% CI 97.3-98.4) |
| id |
UFSP_c6c65679b86801e68596f1eaf33ed5cb |
|---|---|
| oai_identifier_str |
oai:repositorio.unifesp.br/:11600/49285 |
| network_acronym_str |
UFSP |
| network_name_str |
Repositório Institucional da UNIFESP |
| repository_id_str |
3465 |
| spelling |
Access to and use of high blood pressure medications in brazilAcesso e uso de medicamentos para hipertensão arterial no BrasilNoncommunicable DiseasesHypertensionPrevalenceAdultsDrugsOBJECTIVE: To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS: Analysis of data from Pesquisa Nacional Sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS: Prevalence of high blood pressure was 23.7% (95% CI 22.8-24.6). Regarding people with this condition, 93.8% (95% CI 92.8-94.8) had indication for drug therapy and, of those, 94.6% (95% CI 93.5-95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95% CI 97.3-98.4)partial access, 1.9% (95% CI 1.4-2.4)and no access, 0.2% (95% CI 0.1-0.4). The medication used to treat high blood pressure, 56.0% (95% CI 52.6-59.2) were obtained from SUS (Brazilian Unified Health System), 16.0% (95% CI 14.3-17.9) from Popular Pharmacy Program, 25.7% (95% CI 23.4-28.2) were paid for by the patients themselves and 2.3% (95% CI 1.8-2.9) were obtained from other locations. The five most commonly used drugs were, in descending order, hydrochlorothiazide, losartan, captopril, enalapril and atenolol. Of the total number of patients on treatment, 36.1% (95% CI 34.1-37.1) were using two medicines and 13.5% (95% CI 12.3-14.9) used three or more. CONCLUSIONS: Access to medicines for the treatment of high blood pressure may be considered high and many of them are available free of charge. The most commonly used drugs are among those recommended as first-line treatment for high blood pressure control. The percentage of people using more than one drug seems to follow the behavior observed in other countries.Programa de Pós-Graduação em Epidemiologia. Faculdade de Medicina. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, BrasilDepartamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, BrasilDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, BrasilDepartamento de Ciências Farmacêuticas. Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, BrasilDepartamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, BrasilDepartamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, BrasilDepartamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, BrasilDepartamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, BrasilDepartamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, BrasilWeb of ScienceDepartment of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs - SCTIE of the Ministry of Health [25000.111834/2011-31]Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs - SCTIE of the Ministry of Health [25000.111834/2011-31]SCTIE?MS: 25000.111834/2011-31Elsevier Science Bv2019-01-21T10:29:36Z2019-01-21T10:29:36Z2016info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion8shttp://dx.doi.org/10.1590/s1518-8787.2016050006154Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 8s, 2016.10.1590/S1518-8787.2016050006154S0034-89102016000300305.pdf0034-8910S0034-89102016000300305http://repositorio.unifesp.br/handle/11600/49285WOS:000391447400009engRevista De Saude Publicainfo:eu-repo/semantics/openAccessMengue, Sotero SerrateBertoldi, Andrea DamasoRamos, Luiz Roberto [UNIFESP]Farias, Mareni RochaOliveira, Maria AuxiliadoraLeao Tavares, Noemia UrruthDourado Arrais, Paulo SergioLuiza, Vera LuciaDal Pizzol, Tatiane da Silvareponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2022-02-08T12:58:36Zoai:repositorio.unifesp.br/:11600/49285Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652022-02-08T12:58:36Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
| dc.title.none.fl_str_mv |
Access to and use of high blood pressure medications in brazil Acesso e uso de medicamentos para hipertensão arterial no Brasil |
| title |
Access to and use of high blood pressure medications in brazil |
| spellingShingle |
Access to and use of high blood pressure medications in brazil Mengue, Sotero Serrate Noncommunicable Diseases Hypertension Prevalence Adults Drugs |
| title_short |
Access to and use of high blood pressure medications in brazil |
| title_full |
Access to and use of high blood pressure medications in brazil |
| title_fullStr |
Access to and use of high blood pressure medications in brazil |
| title_full_unstemmed |
Access to and use of high blood pressure medications in brazil |
| title_sort |
Access to and use of high blood pressure medications in brazil |
| author |
Mengue, Sotero Serrate |
| author_facet |
Mengue, Sotero Serrate Bertoldi, Andrea Damaso Ramos, Luiz Roberto [UNIFESP] Farias, Mareni Rocha Oliveira, Maria Auxiliadora Leao Tavares, Noemia Urruth Dourado Arrais, Paulo Sergio Luiza, Vera Lucia Dal Pizzol, Tatiane da Silva |
| author_role |
author |
| author2 |
Bertoldi, Andrea Damaso Ramos, Luiz Roberto [UNIFESP] Farias, Mareni Rocha Oliveira, Maria Auxiliadora Leao Tavares, Noemia Urruth Dourado Arrais, Paulo Sergio Luiza, Vera Lucia Dal Pizzol, Tatiane da Silva |
| author2_role |
author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Mengue, Sotero Serrate Bertoldi, Andrea Damaso Ramos, Luiz Roberto [UNIFESP] Farias, Mareni Rocha Oliveira, Maria Auxiliadora Leao Tavares, Noemia Urruth Dourado Arrais, Paulo Sergio Luiza, Vera Lucia Dal Pizzol, Tatiane da Silva |
| dc.subject.por.fl_str_mv |
Noncommunicable Diseases Hypertension Prevalence Adults Drugs |
| topic |
Noncommunicable Diseases Hypertension Prevalence Adults Drugs |
| description |
OBJECTIVE: To analyze the access to and use of medicines for high blood pressure among the Brazilian population according to social and demographic conditions. METHODS: Analysis of data from Pesquisa Nacional Sobre Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines), a nationwide cross-sectional, population-based study, with probability sampling, carried out between September 2013 and February 2014 in urban households in the five Brazilian regions. The study evaluated the access and use of medicines to treat people with high blood pressure. The independent variables were gender, age, socioeconomic status and Brazilian region. The study also described the most commonly used drugs and the percentage of people treated with one, two, three or more drugs. Point estimations and confidence intervals were calculated considering the sample weights and sample complex plan. RESULTS: Prevalence of high blood pressure was 23.7% (95% CI 22.8-24.6). Regarding people with this condition, 93.8% (95% CI 92.8-94.8) had indication for drug therapy and, of those, 94.6% (95% CI 93.5-95.5) were using the medication at the time of interview. Full access to medicines was 97.9% (95% CI 97.3-98.4) |
| publishDate |
2016 |
| dc.date.none.fl_str_mv |
2016 2019-01-21T10:29:36Z 2019-01-21T10:29:36Z |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/s1518-8787.2016050006154 Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 8s, 2016. 10.1590/S1518-8787.2016050006154 S0034-89102016000300305.pdf 0034-8910 S0034-89102016000300305 http://repositorio.unifesp.br/handle/11600/49285 WOS:000391447400009 |
| url |
http://dx.doi.org/10.1590/s1518-8787.2016050006154 http://repositorio.unifesp.br/handle/11600/49285 |
| identifier_str_mv |
Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 8s, 2016. 10.1590/S1518-8787.2016050006154 S0034-89102016000300305.pdf 0034-8910 S0034-89102016000300305 WOS:000391447400009 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
Revista De Saude Publica |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
8s |
| dc.publisher.none.fl_str_mv |
Elsevier Science Bv |
| publisher.none.fl_str_mv |
Elsevier Science Bv |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
| instname_str |
Universidade Federal de São Paulo (UNIFESP) |
| instacron_str |
UNIFESP |
| institution |
UNIFESP |
| reponame_str |
Repositório Institucional da UNIFESP |
| collection |
Repositório Institucional da UNIFESP |
| repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
| repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
| _version_ |
1814268347390361600 |